Kumar A - Search Results

1

Performance of AGO score for secondary cytoreduction in a high-volume U.S. center.

Janco JM, Kumar A, Weaver AL, McGree ME, Cliby WA. Janco JM, et al. Among authors: kumar a. Gynecol Oncol. 2016 Apr;141(1):140-7. doi: 10.1016/j.ygyno.2016.01.027. Epub 2016 Feb 2. Gynecol Oncol. 2016. PMID: 26836496

2

Impact of obesity on surgical and oncologic outcomes in ovarian cancer.

Kumar A, Bakkum-Gamez JN, Weaver AL, McGree ME, Cliby WA. Kumar A, et al. Gynecol Oncol. 2014 Oct;135(1):19-24. doi: 10.1016/j.ygyno.2014.07.103. Epub 2014 Aug 7. Gynecol Oncol. 2014. PMID: 25110330

3

Surgical morbidity and clinical outcomes in ovarian cancer - the role of obesity.

Smits A, Lopes A, Das N, Kumar A, Cliby W, Smits E, Bekkers R, Massuger L, Galaal K. Smits A, et al. Among authors: kumar a. BJOG. 2016 Jan;123(2):300-8. doi: 10.1111/1471-0528.13585. BJOG. 2016. PMID: 26331299 Review.

4

Risk-prediction model of severe postoperative complications after primary debulking surgery for advanced ovarian cancer.

Kumar A, Janco JM, Mariani A, Bakkum-Gamez JN, Langstraat CL, Weaver AL, McGree ME, Cliby WA. Kumar A, et al. Gynecol Oncol. 2016 Jan;140(1):15-21. doi: 10.1016/j.ygyno.2015.10.025. Epub 2015 Nov 2. Gynecol Oncol. 2016. PMID: 26541980

5

Muscle composition measured by CT scan is a measurable predictor of overall survival in advanced ovarian cancer.

Kumar A, Moynagh MR, Multinu F, Cliby WA, McGree ME, Weaver AL, Young PM, Bakkum-Gamez JN, Langstraat CL, Dowdy SC, Jatoi A, Mariani A. Kumar A, et al. Gynecol Oncol. 2016 Aug;142(2):311-6. doi: 10.1016/j.ygyno.2016.05.027. Epub 2016 Jun 2. Gynecol Oncol. 2016. PMID: 27235857

6

Efforts at maximal cytoreduction improve survival in ovarian cancer patients, even when complete gross resection is not feasible.

Wallace S, Kumar A, Mc Gree M, Weaver A, Mariani A, Langstraat C, Dowdy S, Bakkum-Gamez J, Cliby W. Wallace S, et al. Among authors: kumar a. Gynecol Oncol. 2017 Apr;145(1):21-26. doi: 10.1016/j.ygyno.2017.01.029. Epub 2017 Jan 31. Gynecol Oncol. 2017. PMID: 28159407

7

Inflammatory and Nutritional Serum Markers as Predictors of Peri-operative Morbidity and Survival in Ovarian Cancer.

Kumar A, Torres ML, Cliby WA, Kalli KR, Bogani G, Aletti G, Nitschmann CC, Multinu F, Weaver AL, Block MS, Mariani A. Kumar A, et al. Anticancer Res. 2017 Jul;37(7):3673-3677. doi: 10.21873/anticanres.11738. Anticancer Res. 2017. PMID: 28668859 Free article.

8

Functional not chronologic age: Frailty index predicts outcomes in advanced ovarian cancer.

Kumar A, Langstraat CL, DeJong SR, McGree ME, Bakkum-Gamez JN, Weaver AL, LeBrasseur NK, Cliby WA. Kumar A, et al. Gynecol Oncol. 2017 Oct;147(1):104-109. doi: 10.1016/j.ygyno.2017.07.126. Epub 2017 Jul 19. Gynecol Oncol. 2017. PMID: 28734497

9

Concomitant venous thromboembolism at the time of primary EOC diagnosis: Perioperative outcomes and survival analyses.

Kumar A, Hurtt CC, Cliby WA, Martin JR, Weaver AL, McGree ME, Langstraat CL, Bakkum-Gamez JN. Kumar A, et al. Gynecol Oncol. 2017 Dec;147(3):514-520. doi: 10.1016/j.ygyno.2017.09.020. Epub 2017 Sep 22. Gynecol Oncol. 2017. PMID: 28947173

10

Intraperitoneal disease dissemination patterns are associated with residual disease, extent of surgery, and molecular subtypes in advanced ovarian cancer.

Torres D, Kumar A, Wallace SK, Bakkum-Gamez JN, Konecny GE, Weaver AL, McGree ME, Goode EL, Cliby WA, Wang C. Torres D, et al. Among authors: kumar a. Gynecol Oncol. 2017 Dec;147(3):503-508. doi: 10.1016/j.ygyno.2017.09.021. Epub 2017 Sep 28. Gynecol Oncol. 2017. PMID: 28964622 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

31,980 results

Search Page

Filters